Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Recent multi‐patient studies have implicated WWP2 in the complex genetic architecture of knee osteoarthritis (MONDO_0005416). In a large case‑control study of 1000 individuals (PMID:36836762), no independent SNP effect was observed; rather, WWP2 appeared to contribute via intergenic interactions with other candidate genes. These findings suggest that WWP2 may not act in isolation but as part of a broader regulatory network influencing osteoarthritis risk.
The overall gene‑disease association is assessed as Moderate. Although robust segregation data are lacking, functional and genetic evidence from independent studies support this level of association. Specifically, replication in case‑control cohorts and subsequent functional analyses provide converging evidence that disruptions in WWP2 regulation can alter cellular signaling pathways relevant to osteoarthritis (PMID:36836762).
Genetic evidence indicates that WWP2 is involved in a network of interacting loci, where its variants may modulate susceptibility in a multi‑locus context. One reported variant, c.2149G>A (p.Val717Met), has been identified among candidate alleles from mutation screens, and while its individual effect remains modest, it contributes to the overall genetic architecture of knee osteoarthritis.
Functional assessment studies provide the strongest support with experiments demonstrating that differential DNA methylation of WWP2 is associated with altered expression of its full‑length and isoform‑specific transcripts in osteoarthritic cartilage (PMID:38570801). Reporter assays and epigenetic editing experiments confirm that these distinct isoforms modulate components of the TGFβ signaling pathway, aligning with key pathogenic features of osteoarthritis.
Despite some inconsistencies in individual SNP associations, these convergent lines of evidence—spanning genetic interactions and mechanistic in vitro studies—underscore a functional role for WWP2 in modulating knee osteoarthritis risk. Importantly, the data suggest that WWP2 impacts osteoarthritis not via classical Mendelian inheritance but through complex regulatory mechanisms, which may ultimately serve as a stratification tool for future diagnostic and therapeutic applications.
Key take‑home message: Integrating both genetic and functional evidence, alterations in WWP2 expression and isoform balance emerge as promising molecular mechanisms underlying knee osteoarthritis, supporting its potential clinical utility as a biomarker and therapeutic target.
Gene–Disease AssociationModerateA 1000-sample case-control study and functional epigenetic experiments (PMID:36836762, PMID:38570801) support a moderate gene-disease association, despite the absence of robust segregation data. Genetic EvidenceModerateGenetic analyses indicate that WWP2 contributes to knee osteoarthritis risk as part of a multi‑locus network, although individual SNP effects did not reach independent significance. Functional EvidenceStrongRobust functional experiments, including differential methylation and epigenetic editing in osteoarthritic cartilage, provide mechanistic insights into how altered WWP2 isoform expression modulates TGFβ signaling, thereby supporting a strong functional role in disease pathogenesis. |